FDLI's one and a half day conference in Toronto, Canada provides an opportunity to hear directly from internationally renowned experts on game-changing developments and comparisons in food, medical device, cosmetics and drug law in the U.S. and Canada. FDLI has invited officials from both governments to address first-hand how the U.S. Food and Drug Administration and Health Canada are working together to harmonize regulatory frameworks as well as how their regulatory schemes differ. The conference will also focus on business opportunities and policy challenges to producing safe products and promoting public health. The event will cover key emerging issues in both countries, including:
- Trade issues affecting U.S. and Canadian food, drug, cosmetics and device manufacturers;
- Latest developments in patent law protection in the U.S. and Canada;
- Classification of medical products in Canada and the U.S. cGMP compliance and quality system standards in Canada and the U.S.;
- Regulatory alignment (GMPs and inspections as they apply to OTC cosmetic products), cosmetic packaging and labeling requirements alignment, and the consideration/alignment of environmental, health, and safety reviews;
- Similarities and differences between the Food Safety Modernization Act and the Safe Food for Canadians Act;
- How food labeling and health claims are approved and regulated in the two countries; and
- How Mexico and NAFTA fit into the North American business paradigm.